0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Viewpoint |  FREE ONLINE FIRST
Steven J. Katz, MD, MPH; Allison W. Kurian, MD, MSc; Monica Morrow, MD
JAMA. Published online July 23, 2015. doi:10.1001/jama.2015.8088

Editorial | 
Boris Pasche, MD, PhD; Stefan C. Grant, MD, JD, MBA
JAMA. 2014;311(19):1975-1976. doi:10.1001/jama.2014.3742.

Original Investigation |  FREE
Mark G. Kris, MD; Bruce E. Johnson, MD; Lynne D. Berry, PhD; et al.
JAMA. 2014;311(19):1998-2006. doi:10.1001/jama.2014.3741.
Includes: CME, Supplemental Content

Viewpoint | 
Robert T. McCormack, PhD; Joanne Armstrong, MD, MPH; Debra Leonard, MD, PhD
JAMA. 2014;311(14):1395-1396. doi:10.1001/jama.2014.1508.

Editorial | 
Donald J. Buchsbaum, PhD; Carlo M. Croce, MD
JAMA. 2014;311(4):363-365. doi:10.1001/jama.2013.284665.

Preliminary Communication |  FREE
Nicolai A. Schultz, MD, PhD; Christian Dehlendorff, PhD; Benny V. Jensen, MD; et al.
JAMA. 2014;311(4):392-404. doi:10.1001/jama.2013.284664.
Includes: Supplemental Content

Viewpoint | 
Yvonne Bombard, PhD; Mark Robson, MD; Kenneth Offit, MD, MPH
JAMA. 2013;310(8):795-796. doi:10.1001/jama.2013.276573.

Original Investigation |  FREE
Maarten C. Bosland, DVSc, PhD; Ikuko Kato, MD, PhD; Anne Zeleniuch-Jacquotte, MS, MD; et al.
JAMA. 2013;310(2):170-178. doi:10.1001/jama.2013.7842.
Includes: Supplemental Content

Medical News and Perspectives | 
Tracy Hampton, PhD
JAMA. 2013;309(5):427-429. doi:10.1001/jama.2012.196394.

Original Contribution |  FREE
Leticia Moreira, MD; Francesc Balaguer, MD, PhD; Noralane Lindor, MD; et al.
JAMA. 2012;308(15):1555-1565. doi:10.1001/jama.2012.13088.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Review  | 
The Evolving Landscape of HER2 Targeting in Breast Cancer
Mark M. Moasser, MD; Ian E. Krop, MD, PhD
JAMA Ophthalmology
Original Investigation  | 
Association of Cone-Rod Homeobox Transcription Factor Messenger RNA With Pediatric Metastatic Retinoblastoma
Ana V. Torbidoni, PhD; Viviana E. Laurent, MSc; Claudia Sampor, MD; et al.
JAMA Oncology
Viewpoint  | 
How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy
Michael D. Farwell, MD; Amy S. Clark, MD, MSCE; David A. Mankoff, MD, PhD
JAMA Oncology
Original Investigation  | 
Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial
Roberto Salgado, MD, PhD; Carsten Denkert, MD, PhD; Christine Campbell, MSc; et al.